Skip to main content
logo
Caris Life Sciences, Inc. (CAI)
NASDAQ: CAI · Real-Time Price · USD
24.94
+0.15 (0.63%)
Sep 2, 2026, 11:43 AM EDT - Market open

Caris Life Sciences Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22
Market Capitalization
7,0477,612---
Market Cap Growth
-34.73%----
Enterprise Value
6,7067,284---
Last Close Price
24.7826.98---

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22
Forward PE
87.71294.73---
PS Ratio
7.089.37---
PB Ratio
11.8313.19---
P/TBV Ratio
12.2313.64---
P/FCF Ratio
56.49113.80---
P/OCF Ratio
41.5491.54---

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22
EV/Sales Ratio
6.738.97---
EV/EBITDA Ratio
38.28107.54---
EV/EBIT Ratio
43.47161.45---
EV/FCF Ratio
53.74108.88---

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22
Debt / Equity Ratio
0.770.74-1.53-11.041.08
Debt / EBITDA Ratio
2.455.45---
Debt / FCF Ratio
3.656.39---
Net Debt / Equity Ratio
-0.58-0.64-1.29-4.86-0.55
Net Debt / EBITDA Ratio
-1.96-5.48-1.72-0.350.52
Net Debt / FCF Ratio
-2.75-5.54-1.41-0.320.42
Asset Turnover
0.911.111.090.54-
Inventory Turnover
3.635.255.244.48-
Quick Ratio
4.757.160.931.863.29
Current Ratio
5.537.851.302.553.77
Return on Equity (ROE)
20.13%-45.37%--293.82%-
Return on Assets (ROA)
8.77%3.84%-42.48%-35.34%-
Return on Capital Employed (ROCE)
14.80%4.50%-144.20%-100.60%-54.40%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22
Earnings Yield
1.50%-0.89%---
FCF Yield
1.77%0.88%---
Buyback Yield / Dilution
-559.05%-371.04%-1.59%-4.73%-
SEC Filings: 10-K · 10-Q